中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
10期
74-76
,共3页
抗生素%益生菌制剂%腹泻型肠易激综合征%症状评分%治疗效果
抗生素%益生菌製劑%腹瀉型腸易激綜閤徵%癥狀評分%治療效果
항생소%익생균제제%복사형장역격종합정%증상평분%치료효과
Antibiotics%Probiotics%IBS-D%Symptom score%Therapeutic effect
目的:探讨抗生素和益生菌制剂治疗腹泻型肠易激综合征的临床效果。方法选取本院2011年10月~2013年10月诊治的腹泻型肠易激综合征患者128例,根据治疗方案分为两组,64例患者采用益生菌制剂治疗为对照组,64例患者采用抗生素和益生菌制剂治疗为观察组,疗程8周,在治疗前后不同时间点给予患者症状评分,比较两组患者的治疗效果。结果观察组患者在治疗2周、4周、6周、8周时症状评分均明显低于对照组,观察组患者总有效率(98.44%)明显高于对照组(87.50%),差异均有统计学意义(P<0.05)。结论抗生素和益生菌制剂是治疗腹泻型肠易激综合征的有效药物,可明显改善患者的临床病症,显著提高疾病的治疗效果。
目的:探討抗生素和益生菌製劑治療腹瀉型腸易激綜閤徵的臨床效果。方法選取本院2011年10月~2013年10月診治的腹瀉型腸易激綜閤徵患者128例,根據治療方案分為兩組,64例患者採用益生菌製劑治療為對照組,64例患者採用抗生素和益生菌製劑治療為觀察組,療程8週,在治療前後不同時間點給予患者癥狀評分,比較兩組患者的治療效果。結果觀察組患者在治療2週、4週、6週、8週時癥狀評分均明顯低于對照組,觀察組患者總有效率(98.44%)明顯高于對照組(87.50%),差異均有統計學意義(P<0.05)。結論抗生素和益生菌製劑是治療腹瀉型腸易激綜閤徵的有效藥物,可明顯改善患者的臨床病癥,顯著提高疾病的治療效果。
목적:탐토항생소화익생균제제치료복사형장역격종합정적림상효과。방법선취본원2011년10월~2013년10월진치적복사형장역격종합정환자128례,근거치료방안분위량조,64례환자채용익생균제제치료위대조조,64례환자채용항생소화익생균제제치료위관찰조,료정8주,재치료전후불동시간점급여환자증상평분,비교량조환자적치료효과。결과관찰조환자재치료2주、4주、6주、8주시증상평분균명현저우대조조,관찰조환자총유효솔(98.44%)명현고우대조조(87.50%),차이균유통계학의의(P<0.05)。결론항생소화익생균제제시치료복사형장역격종합정적유효약물,가명현개선환자적림상병증,현저제고질병적치료효과。
ObjectiveTo investigate the clinical effect of antibiotics and probiotics in treatment for IBS-D. Methods128 patients with IBS-D were selected in hospital from October 2011 to October 2013. According to treatment, the patients were divided into two groups. 64 patients treated probiotics as control group. 64 patients treated antibiotics and probiotics as observation group. Course of treatment was 8 weeks. Symptom scores were finished in different time points before and after treatment. Therapeutic effect was compared between two groups. Results Symptom scores at 2 weeks,4 weeks,6 weeks,8 weeks in observation group were significantly lower than control group. Total efficiency in observation group(98.44%) was significantly higher than control group(87.50%). Differences were statistically significant(P<0.05).Conclusion Antibiotics and probiotics are effective drugs in treatment for IBS-D, which can significantly improve clinical symptoms and improve therapeutic effect.